These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 10364790

  • 21. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC.
    Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088
    [Abstract] [Full Text] [Related]

  • 22. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD, Mashinter LD, Lindemulder A, Taylor GD, Chiu I.
    HIV Med; 2007 Jul 01; 8(5):295-9. PubMed ID: 17561875
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T, Chantaphakul N, Thanwandee T, Ong-Ajyooth L.
    J Med Assoc Thai; 2006 Aug 01; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG, Schiff M, Graves B, Agosti J, Barritt ML, Garner D, Holley JL.
    Clin Nephrol; 2000 Aug 01; 54(2):138-42. PubMed ID: 10968690
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC.
    Int J Infect Dis; 2007 Sep 01; 11(5):394-401. PubMed ID: 17257877
    [Abstract] [Full Text] [Related]

  • 30. [The response to the hepatitis B virus vaccine in patients undergoing hemodialysis and peritoneal dialysis--personal experience].
    Majdan M, Polz M, Ksiazek A, Janicka L, Kozioł M, Swatowski A, Orłowska G.
    Przegl Lek; 1995 Sep 01; 52(6):307-10. PubMed ID: 7568985
    [Abstract] [Full Text] [Related]

  • 31. Immuneresponse to recombinant hepatitis B vaccination in adults.
    Gandhoke I, Gupta S, Lal S, Khare S.
    J Commun Dis; 2003 Dec 01; 35(4):249-55. PubMed ID: 15909752
    [Abstract] [Full Text] [Related]

  • 32. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
    Thaithumyanon P, Punnahitananda S, Praisuwanna P, Thisyakorn U, Ruxrungtham K.
    J Med Assoc Thai; 2002 Mar 01; 85(3):277-82. PubMed ID: 12117014
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
    Urbanowicz W.
    Przegl Epidemiol; 2000 Mar 01; 54(3-4):343-50. PubMed ID: 11349597
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Prospective study of HBV circulation and long-term evaluation of anti-hepatitis-B vaccination in patients undergoing hemodialysis].
    Portelli V, Cesare S, Galanti B, Genovese G, Pappalardo MS, Colimberti D.
    Boll Ist Sieroter Milan; 1990 Jun 01; 69(2):469-73. PubMed ID: 2152307
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
    Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, Schroeder S, Halm U, Mössner J, Berr F.
    Hepatology; 2000 Jan 01; 31(1):230-4. PubMed ID: 10613751
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.